1 Min Read
July 7 (Reuters) - Acorda Therapeutics Inc:
* Christopher M. James reports a 5.9 percent passive stake in Acorda Therapeutics Inc as of June 27, 2017- sec filing Source text (bit.ly/2tz6Pgg) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.